WYETH-LEDERLE ACEL-IMUNE RECOMMENDED FOR FIRST FOUR DOSES OF PRIMARY IMMUNIZA-TION SERIES; ADDITIONAL FIFTH DOSE SAFETY DATA NEEDED FOR APPROVAL
Executive Summary
Additional fifth dose data will be needed to support the safety of Wyeth-Lederle's Acel-Imune (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed) for use after four previous doses of the DTaP vaccine, FDA's Vaccines & Related Biological Products Advisory Committee agreed at an Oct. 29 meeting.